Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging. - Wikidata - wikimedia - TriplyDB

Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.

Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.

http://www.wikidata.org/entity/Q46821567

about

Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis Imaging and interventions in hilar cholangiocarcinoma: A review Clinical application of 18F-fluorodeoxyglucose positron emission tomography for assessment and evaluation after therapy for malignant hepatic tumor Cholangiocarcinoma: Current Knowledge and New Developments Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection.Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation Is there any role of positron emission tomography computed tomography for predicting resectability of gallbladder cancer?FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile?NCCN clinical practice guidelines in oncology: hepatobiliary cancers Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases.Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis.Clinical impact of FDG PET-CT on management decisions for patients with primary biliary tumours.The current role of PET-CT in the characterization of hepatobiliary malignancies.Cholangiocarcinoma: has there been any progress?Surgical outcomes of intrahepatic cholangiocarcinoma.Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.Imaging bile duct tumors: staging.Hepatocellular carcinoma and cholangiocarcinoma: an update.A review of the clinical diagnosis and therapy of cholangiocarcinoma.The treatment of cholangiocarcinoma: a hepatologist's perspective.Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation.Management of Malignant Biliary Obstruction.Imaging of Cholangiocarcinoma.Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT.Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in the evaluation of the primary tumor in patients with cholangiocarcinoma: a meta-analysis Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.The Role of F-18 FDG PET/CT in Intrahepatic Cholangiocarcinoma.Late recurrence after resection of mass-forming intrahepatic cholangiocarcinoma: report of a case.Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging

P2860

Q26785922-95AD87B0-0829-4F84-9E4D-4BA141189968 Q26823900-34E25250-A421-48E5-9B32-9D2826A2380F Q27005824-65127AAC-78BE-44EE-ABA5-DFCFC410949D Q28076098-F9F85889-05F2-44D1-9275-0B4D993F1CF9 Q31014798-6F555DFE-EB6E-4C29-9AF1-34C4D5574751 Q33594891-F0863A97-5E53-4B08-B324-EEDFB97D5350 Q33627586-1E2356F4-69A4-4C04-8049-50BC9CA885B9 Q34846267-DBC9AC22-4E3F-47D1-B0B3-8E859401DE62 Q35183539-F3B003D5-7D8B-45CB-B260-7673B5B3069F Q35703937-D1F7E6B3-EA77-48A1-8511-36F3C93267A2 Q35971464-E78AB5E0-54A3-4F73-8FD3-CAD9EAC1B98E Q36064847-F4DBED83-2737-4AC8-9A35-2F584484EDA7 Q37077299-8A8BAEB1-808C-4AE1-A5EE-D36419661B62 Q37192828-1E23AD24-76F7-4C92-9A57-24C417217440 Q37546832-29068C79-626E-4D24-950B-85D0842F1A19 Q37698980-F0C9F791-0B0E-43EF-82A8-1497076CE3AB Q37900232-0700A989-551E-4840-9854-20DCCC2E5C9C Q37998654-BEB408F5-E4A2-4C7C-B046-BBB12974DA5B Q38004855-F349DB39-4A75-4CA3-9A91-66E9132FC03B Q38030862-115986BF-0D6B-4AD9-A0FD-7560157C2262 Q38059510-FE6A9E57-F22F-4A15-AFAD-F9A1BDDDB132 Q38116396-2DCFCFF9-C601-440A-B668-EC4BF7B1A51B Q38163597-F4174257-1068-4F14-8058-B574BC089D43 Q38173689-EFE77DF1-898A-4764-8368-679324B3C2D9 Q38245695-D097D651-7E68-468F-8E96-1B76AC5A238A Q38723527-D26A6C21-5AD1-463B-9D0D-54E8CAFAD67E Q39025104-FC3E7D49-C5BE-4EF6-ABD9-F90DE8A2CE5F Q39147313-0E21AFE0-0482-4142-97E7-49A7702BAF8D Q39167413-3ACB539B-DC00-4B60-942D-7F63EA1A1ABD Q39368078-24A55F96-2923-4213-B880-92BE4FDC6F20 Q39431117-6FE8F5C1-E17A-47C4-B785-D1986113A384 Q40554841-F75B1E7E-FF30-442D-B5FE-76CE246972A9 Q44017699-0211F248-1864-4CEF-88B7-EDEFD8759FC1 Q47640222-9A11521F-DE6C-4363-94DE-429E6FB56111 Q47843423-D2C055D3-8106-42A7-A0F6-77DBF9A1274C Q51311016-D881DEF1-2F37-4475-B838-59299EF3D67A Q57113192-0D8D2883-5637-447B-B88E-3C8FF4F90E2E

P2860

Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.

http://www.wikidata.org/entity/Q46821567

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@en

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@nl

type

label

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@en

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@nl

prefLabel

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@en

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@nl

P1433

Q46821567-BB76DA23-3417-4F07-9D3B-384D454C4F8C

P1476

Q46821567-CD4EBF69-CF0C-4F49-A229-72CE18B3FE8D

P2093

Q46821567-0A4FF7B9-4147-45AB-9D1A-A05B6F4F059F

Q46821567-1F41C0D2-50CC-4550-8BB8-127B7A25580E

Q46821567-4B9C0A29-292F-4A4F-A34A-2C20FC28B581

Q46821567-4CA298F5-DAC3-4860-99A1-6DA113AFE54C

Q46821567-9B16CEE0-4B93-4E94-BBF9-4B637F3F276E

Q46821567-B8BDABC9-B4DA-4715-B9CA-9704B4B3F8C8

Q46821567-DF376181-2BD7-492D-8998-1419B165BF2C

Q46821567-F7B1D678-F151-4AAE-AC69-4CA383EFCEF1

Q46821567-FF848388-59EC-4A02-80F3-9942495E9B35

P2860

Q46821567-03582504-456C-4BA8-8973-1755B479AC91

Q46821567-0A26B39F-5C91-45C5-863F-46A31E99BA01

Q46821567-132EFC9F-062F-49F8-BEFA-3ACF05AF0F3A

Q46821567-1FA94D1B-4B12-4858-B1C4-CC0F31E18243

Q46821567-2DDD4B3A-D549-49F4-BF2F-4432C0696CED

Q46821567-36CBC50D-57C2-4754-8604-3B97A3D1D5A9

Q46821567-54EDC5C6-BB17-4538-917A-52654B4BB5E5

Q46821567-6F9AD8C8-D4BF-4288-9A02-1079E7F028F7

Q46821567-704CF813-0575-4C41-913A-7358813372AA

Q46821567-738D4131-D07F-4D8B-9276-B700F2831EA8

P304

Q46821567-A27F09C7-A73A-4D10-BF8F-0B28E2DB858F

P31

Q46821567-1654FD8B-AFBA-45B3-9B3D-888A22E01B3D

P356

Q46821567-B82C1AF9-30EC-491A-ABDC-9D8FC1CD05B5

P407

Q46821567-AE0D1766-9097-4300-AB5A-42533184F3F8

P433

Q46821567-A2D6BBF9-EA9E-411B-AD26-F755ED526BFC

P478

Q46821567-12736686-B75A-4830-95F3-48A07ACA24FB

P577

Q46821567-174C45FD-1171-4EC3-B271-535B6513057F

P5875

Q46821567-EA6CBB86-AC6B-44D8-9631-907FEB17E239

P698

Q46821567-02467C13-C936-4651-BAD8-1680DEF61418

P921

Q46821567-9CFEEF74-4EAD-4744-9CFA-85637E87BAA7

P356

J.1572-0241.2007.01710.X

P1433

The American Journal of Gastroenterology

P1476

Clinical role of 18F-FDG PET-C ...... red with conventional imaging.

@en

P2093

Chang Y Hwang

http://www.w3.org/2001/XMLSchema#string

Dong W Seo

http://www.w3.org/2001/XMLSchema#string

Jae S Kim

http://www.w3.org/2001/XMLSchema#string

Ji Y Kim

http://www.w3.org/2001/XMLSchema#string

Myung-Hwan Kim

http://www.w3.org/2001/XMLSchema#string

Sang S Lee

http://www.w3.org/2001/XMLSchema#string

Sung K Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Cheol Yun

http://www.w3.org/2001/XMLSchema#string

Tae Y Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Biliary tract cancers.

Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings.

Early bile duct cancer.

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

A review and update on cholangiocarcinoma.

Pearls and pitfalls in interpretation of abdominal and pelvic PET-CT.

Clinicopathological review of 61 patients with early bile duct cancer.

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

FDG PET in the diagnosis of hilar cholangiocarcinoma.

Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

P304

1145-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1572-0241.2007.01710.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5673646

http://www.w3.org/2001/XMLSchema#string

P698

18177454

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma